Skip to main content

and
  1. Article

    Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of Carbohydrates in Diabetes): a randomised controlled trial

    We recently found that oral glucose tolerance over 1 year in type 2 diabetic patients declined to a significantly lesser degree on a low-glycaemic-index than on a reduced-carbohydrate diet. Here, we examined w...

    T. M. S. Wolever, C. Mehling, J.-L. Chiasson, R. G. Josse, L. A. Leiter in Diabetologia (2008)

  2. Article

    Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC-1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial

    We investigated the effects of the common polymorphisms in the peroxisome proliferator-activated receptor γ2 (PPAR-γ2; Pro12Ala) and in PPAR-γ coactivator 1α (PGC-1α; Gly482Ser) genes on the conversion from impai...

    L. Andrulionytè, J. Zacharova, J.-L. Chiasson, M. Laakso in Diabetologia (2004)

  3. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)

  4. Article

    Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

    The STOP-NIDDM Trial has shown that acarbose treatment in subjects with impaired glucose tolerance is associated with a significant risk reduction in the development of diabetes, hypertension and cardiovascula...

    J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso in Diabetologia (2004)

  5. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)

  6. No Access

    Article

    Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes

    OBJECTIVES: To see if the long-term treatment of non-insulin dependent diabetes (NIDDM) with the α-glucosidase inhibitor acarbose affects food intake and body weight. DESIGN: Randomized, double-blind, placebo-...

    TMS Wolever, J-L Chiasson, RG Josse, JA Hunt in International Journal of Obesity (1997)

  7. No Access

    Article

    Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss

    OBJECTIVE: To study the effect of fluoxetine, a specific serotonin reuptake inhibitor, on insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus (NIDDM) independently of its action ...

    P Maheux, F Ducros, J Bourque, J Garon, J-L Chiasson in International Journal of Obesity (1997)